351 related articles for article (PubMed ID: 10591653)
1. Mouse tumor model for neurofibromatosis type 1.
Vogel KS; Klesse LJ; Velasco-Miguel S; Meyers K; Rushing EJ; Parada LF
Science; 1999 Dec; 286(5447):2176-9. PubMed ID: 10591653
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of tumor development in neurofibromatosis type 1.
Cichowski K; Shih TS; Schmitt E; Santiago S; Reilly K; McLaughlin ME; Bronson RT; Jacks T
Science; 1999 Dec; 286(5447):2172-6. PubMed ID: 10591652
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1: II. Answers from animal models.
Lakkis MM; Tennekoon GI
J Neurosci Res; 2001 Aug; 65(3):191-4. PubMed ID: 11494353
[No Abstract] [Full Text] [Related]
5. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
6. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1.
Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R
Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306
[TBL] [Abstract][Full Text] [Related]
8. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
10. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
12. Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation.
Hirbe AC; Dahiya S; Friedmann-Morvinski D; Verma IM; Clapp DW; Gutmann DH
Oncotarget; 2016 Feb; 7(7):7403-14. PubMed ID: 26859681
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
14. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of neurofibromatosis type I: bridging the GAP.
Costa RM; Silva AJ
Trends Mol Med; 2003 Jan; 9(1):19-23. PubMed ID: 12524206
[TBL] [Abstract][Full Text] [Related]
16. Modeling neurofibromatosis type 1 tumors in the mouse for therapeutic intervention.
Parada LF; Kwon CH; Zhu Y
Cold Spring Harb Symp Quant Biol; 2005; 70():173-6. PubMed ID: 16869751
[TBL] [Abstract][Full Text] [Related]
17. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
[TBL] [Abstract][Full Text] [Related]
18. Nf1 has an essential role in endothelial cells.
Gitler AD; Zhu Y; Ismat FA; Lu MM; Yamauchi Y; Parada LF; Epstein JA
Nat Genet; 2003 Jan; 33(1):75-9. PubMed ID: 12469121
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations.
Carroll SL; Stonecypher MS
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1115-23. PubMed ID: 15581179
[TBL] [Abstract][Full Text] [Related]
20. Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene.
Oguzkan S; Terzi YK; Güler E; Derbent M; Agras PI; Saatci U; Ayter S
Cancer Genet Cytogenet; 2006 Jan; 164(2):159-63. PubMed ID: 16434322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
